Advancing Treatments for Rare Eye Diseases in Europe
Restore Vision is developing new treatments for rare eye diseases through collaborative research across Europe. By working together with patients, clinicians and researchers, we aim to improve our understanding of these conditions and accelerate the development of safe and effective therapies.
Living with a rare eye disease? Help advance new treatments by participating in Restore Vision research.
Join our research
+30 million
people suffer from blindness and visual impairment
Participate in our research
Your involvement is key in the Restore Vision project. By taking part in our research, you can help us better understand these conditions, improve future treatments, and shape research that reflects the needs and experiences of the community. There are several ways how you can get involved: by participating in our observational study, in our clinical trial, or by sharing your perspective in our Patients Working Group. Go to each page to learn more.
Watch our video
And learn more about the Restore Vision consortium, joining 10 international academic, research and industrial partners.
Project in numbers
0
Study centres
0
First-in-human clinical trials ongoing
0
Clinical trials in preparation
0
Intellectual Properties filed
0
Publications
News
Read Restore Vision’s latest news.
01 June 2026
RestoreVision at the 8th European Aniridia Conference
This April, the city of Sofia, Bulgaria, welcomed the global aniridia community for the 8th European Aniridia Conference (EAC) – a gathering held every two years where patients, doctors and researchers come together to share knowledge and push for better treatments.
Read more
28 February 2026
Surgeries, complications and emergency hospital visits – life with aniridia
“It often feels as if I have lived at the eye hospital more than at home, due to surgeries, complications, and emergency visits.” This is the story from Marie Olsson, 44 years old from a small town called Katrineholm in Sweden, who was born with an eye condition called aniridia.
Read more
25 November 2025
Restore Vision’s latest progress
Where do we stand now in our journey of advancing treatments for rare eye diseases in Europe?
Read more
09 October 2025
A journey of resilience and adaptability – life with aniridia
Today it’s World Sight Day – a global awareness day dedicated to the importance of eye health, vision care, and the prevention of blindness and visual impairment. Behind this message are real-life stories of people dealing with visual impairment. Today, we share the story of Irma, 38 years old, originally from Lithuania, and mother of two children – a daughter of 12 and son of 8 years old. Her son was born with a rare genetic eye condition, called aniridia.
Read more
22 July 2025
New study: Enhancing Immune Modulation with “trained” MSC-EVs
In this study, the Restore Vision team at Galway explored whether EVs from MSCs that were specially “trained” using two immune-related proteins – TGF-β1 and IFN-γ – could more effectively regulate the immune system than EVs from untrained cells.
Read more
Interested in Restore vision?
Stay informed about our efforts to combat rare eye diseases and bring new hope to those affected by visual impairment by subscribing to our newsletter for updates on our latest treatments and research.